FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA
FDA Approves First Interchangeable Biosimilar to Adalimumab, Plus a Combination Drug Approved
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira
Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition
Injection Pen May Reduce Injection Fear Among RA Patients Taking Etanercept Biosimilar
The Race Is On: Clinical Trials Begin for Agents Biosimilar to Denosumab
UnitedHealthcare Designates Avsola, Inflectra Preferred Infliximab Products
Biologics in Rheumatology: Revolution & Perspectives
Biosimilar Prescribing Habits in the VA & Academic Settings
- 1
- 2
- 3
- …
- 8
- Next Page »